Login | New Member? Signup Free
ChangeDetect » News

EMA CHMP adopts positive opinion for Optimer’s DIFICLIR to treat C. difficile infection

Optimer Pharmaceuticals, Inc. today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion for DIFICLIR tablets for the treatment of adults suffering with a Clostridium difficile infection , also known as C. difficile-associated diarrhea.

Tags: , , , , , , , , ,